Shares of Scancell Holdings plc (LON:SCLP – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 11.76 ($0.15) and traded as low as GBX 9.70 ($0.12). Scancell shares last traded at GBX 10.10 ($0.13), with a volume of 289,261 shares.
Scancell Stock Performance
The company’s 50 day moving average price is GBX 10.72 and its 200-day moving average price is GBX 11.76. The company has a debt-to-equity ratio of 61.41, a quick ratio of 13.01 and a current ratio of 8.63. The company has a market cap of £93.71 million, a PE ratio of -1,010.00 and a beta of 0.34.
About Scancell
Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease. Its product candidates include SCIB1, an ImmunoBody cancer vaccine that is in Phase II for the treatment of metastatic melanoma; and SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer.
See Also
- Five stocks we like better than Scancell
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Here are the Pros and Cons of Using Options Call Debit Spreads
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Carmax Returns to the Bargain Basement: Buy the Dip?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.
